The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, October 1996

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 133 patents

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 133 patents that reference this research output.

NEW PROMOTERS

Application EP-4599846-A2

European Patent Office

13 Aug 2025

VACCINE AGAINST PORCINE PARVOVIRUS

Application EP-4570264-A2

European Patent Office

18 Jun 2025

IMMUNOGENIC COMPOSITION USEFUL FOR VACCINATION AGAINST ROTAVIRUS

Application WO-2023194913-A1

World Intellectual Property Organisation (WIPO)

12 Oct 2023

Vesicular stomatitis viruses

Grant US-11634469-B2

United States of America

25 Apr 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 129 additional patents.